IP Library Granted Patent US 7,544,300
Granted Patent B2
US 7,544,300 · App. 11/160,764 · Granted Jun 9, 2009

Batch filtration system for preparation of sterile fluid for renal replacement therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,300
App. No.
11/160,764
Granted
Jun 9, 2009
Kind
B2
Abstract

A method and device for blood treatments that use fluids such as dialysate and replacement fluid for renal replacement therapy. In an embodiment, fluid is passed either by pump or passively by gravity feed, through a microporous sterilization filter from a fluid source to a replacement fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment. As a result, the sterilization filter can have a small capacity. In another embodiment, a filter is placed immediately prior to the point at which the sterile fluid is consumed by the treatment process. The latter may be used in combination with the former embodiment as a last-chance guarantee of sterility and/or that the fluid is free of air bubbles. It may also be used as the primary means of sterile-filtration.

Claims (12)

1. A method of administering a renal replacement therapy requiring a sterile fluid, comprising:

at least one of carbon-filtering, deionizing, and ultra-filtering water to produce a source fluid;

sterile-filtering the source fluid to generate a sterile fluid;

flowing the sterile fluid into a sterile batch container;

the sterile-filtering and flowing being performed at a location and time at which a patient is to be treated;

the at least one of carbon-filtering, deionizing, and ultra-filtering being performed at the location at which the patient is to be treated; and

flowing the sterile fluid from the sterile batch container to a treatment system,

wherein at least one of the sterile-filtering and flowing the sterile fluid into a sterile batch container includes automatically controlling at least one of a flow rate of the sterile fluid and a rate of heating of the sterile fluid responsively to data representing at least one of a treatment start time and a volume of the sterile fluid required for a treatment, and

wherein the flowing the sterile fluid into a sterile batch container includes unsealing a first connector of a connector assembly of the sterile batch container, the first connector assembly being attached to a second filling port of the sterile batch container and reversibly coupling the first connector to an output port of a supply of the sterile fluid.

2. The method of claim 1 , wherein the first connector assembly includes an inline sterile filter effective to isolate the contents of the sterile batch container from ingress of contaminants after the unsealing.

3. The method of claim 2 , wherein the flowing the sterile fluid into a sterile batch container includes decoupling a second connector of the connector assembly, inline with the first connector, thereby leaving the inline sterile filter attached to the output port.

4. The method of claim 3 , wherein the decoupling includes clamping a line of the connector assembly.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2023
From: BOSTIK S.A.
To: MEDHERANT LIMITED
Reel/Frame 065151/0201 →
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2019
From: CAPITAL ONE, NATIONAL ASSOCIATION (AS SUCCESSOR BY MERGER TO HEALTHCARE FINANCIAL SOLUTIONS, LLC)
To: NXSTAGE MEDICAL, INC.
Reel/Frame 048407/0865 →
RELEASE OF SECURITY INTEREST Recorded Jul 28, 2017
From: ASAHI KASEI MEDICAL CO., LTD. F/K/A ASAHI KASEI KURARAY MEDICAL CO., LTD.
To: NXSTAGE MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 043364/0936 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037112/0376 →
RELEASE OF SECURITY INTEREST Recorded Jun 11, 2014
From: SILICON VALLEY BANK
To: NXSTAGE MEDICAL, INC.
Reel/Frame 033133/0902 →
SECURITY INTEREST Recorded Jun 10, 2014
From: NXSTAGE MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 033123/0836 →
SECURITY AGREEMENT Recorded Mar 22, 2010
From: NXSTAGE MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 024114/0789 →
RELEASE OF SECURITY INTEREST Recorded Jun 10, 2009
From: GE BUSINESS FINANCIAL SERVICES INC.
To: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 022804/0150 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 10, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: ASAHI KASEI KURARAY MEDICAL CO., LTD.
Reel/Frame 022804/0496 →
SECURITY AGREEMENT Recorded Apr 7, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: GE BUSINESS FINANCIAL SERVICES INC.
Reel/Frame 022610/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2008
From: BRUGGER, JAMES M.; BURBANK, JEFFREY H.; GREEN, BRIAN C.
To: NXSTAGE MEDICAL, INC.
Reel/Frame 022033/0208 →